Inventor · disambiguated record
Tirtha Chakraborty
Also filed as: CHAKRABORTY TIRTHA
44 granted patents·52 pending applications·2,739 citations·filing 2013–2025
99Inventor score
Files withMODERNA THERAPEUTICS INC33MODERNATX INC30VOR BIOPHARMA INC18VERTEX PHARMA9CRISPR THERAPEUTICS AG2
Top patents by PatentIndex Score
96 records- 0199US10772975B2Modified Polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2017·Granted Sep 15, 2020·37 cites·11 claims
- 0299US9675668B2Modified polynucleotides encoding hepatitis A virus cellular receptor 2MODERNA THERAPEUTICS INC·Filed 2013·Granted Jun 13, 2017·109 cites·14 claims
- 0399US9597380B2Terminally modified RNAMODERNATX INC·Filed 2013·Granted Mar 21, 2017·143 cites·13 claims
- 0499US9587003B2Modified polynucleotides for the production of oncology-related proteins and peptidesMODERNA THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·67 cites·19 claims
- 0599US9572896B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Feb 21, 2017·75 cites·11 claims
- 0699US9572897B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·65 cites·19 claims
- 0799US9504734B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·56 cites·19 claims
- 0899US9301993B2Modified polynucleotides encoding apoptosis inducing factor 1MODERNA THERAPEUTICS INC·Filed 2013·Granted Apr 5, 2016·89 cites·17 claims
- 0999US9303079B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Apr 5, 2016·190 cites·15 claims
- 1099US9283287B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Mar 15, 2016·84 cites·24 claims
- 1199US9254311B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Feb 9, 2016·126 cites·14 claims
- 1299US9233141B2Modified polynucleotides for the production of proteins associated with blood and lymphatic disordersMODERNA THERAPEUTICS INC·Filed 2013·Granted Jan 12, 2016·104 cites·8 claims
- 1399US9220792B2Modified polynucleotides encoding aquaporin-5MODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·101 cites·7 claims
- 1499US9220755B2Modified polynucleotides for the production of proteins associated with blood and lymphatic disordersMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·118 cites·18 claims
- 1599US9221891B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·113 cites·13 claims
- 1699US9192651B2Modified polynucleotides for the production of secreted proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Nov 24, 2015·103 cites·9 claims
- 1799US9114113B2Modified polynucleotides encoding citeD4MODERNA THERAPEUTICS INC·Filed 2013·Granted Aug 25, 2015·121 cites·15 claims
- 1899US9107886B2Modified polynucleotides encoding basic helix-loop-helix family member E41MODERNA THERAPEUTICS INC·Filed 2013·Granted Aug 18, 2015·122 cites·15 claims
- 1999US9095552B2Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1MODERNA THERAPEUTICS INC·Filed 2013·Granted Aug 4, 2015·121 cites·15 claims
- 2099US9089604B2Modified polynucleotides for treating galactosylceramidase protein deficiencyMODERNA THERAPEUTICS INC·Filed 2014·Granted Jul 28, 2015·121 cites·16 claims
- 2199US9061059B2Modified polynucleotides for treating protein deficiencyMODERNA THERAPEUTICS INC·Filed 2014·Granted Jun 23, 2015·208 cites·16 claims
- 2298US9149506B2Modified polynucleotides encoding septin-4MODERNA THERAPEUTICS INC·Filed 2013·Granted Oct 6, 2015·39 cites·15 claims
- 2398US9050297B2Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocatorMODERNA THERAPEUTICS INC·Filed 2013·Granted Jun 9, 2015·32 cites·17 claims
- 2498US8999380B2Modified polynucleotides for the production of biologics and proteins associated with human diseasemodeRNA Therapeutics·Filed 2013·Granted Apr 7, 2015·258 cites·16 claims
- 2597US11027025B2Compositions comprising synthetic polynucleotides encoding CRISPR related proteins and synthetic sgRNAs and methods of useMODERNATX INC·Filed 2014·Granted Jun 8, 2021·40 cites·3 claims
- 2697US9814760B2Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2015·Granted Nov 14, 2017·15 cites·12 claims
- 2797US9216205B2Modified polynucleotides encoding granulysinMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 22, 2015·15 cites·15 claims
- 2896US9782462B2Modified polynucleotides for the production of proteins associated with human diseaseMODERNA THERAPEUTICS INC·Filed 2016·Granted Oct 10, 2017·7 cites·19 claims
- 2995US10925935B2Terminally Modified RNAMODERNA TX INC·Filed 2018·Granted Feb 23, 2021·18 cites·37 claims
- 3095US10155029B2Terminally modified RNAMODERNATX INC·Filed 2017·Granted Dec 18, 2018·12 cites·15 claims
- 3195US9827332B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 28, 2017·7 cites·33 claims
- 3292US9255129B2Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1MODERNA THERAPEUTICS INC·Filed 2013·Granted Feb 9, 2016·4 cites·16 claims
- 3391US9828416B2Modified polynucleotides for the production of secreted proteinsMODERNATX INC·Filed 2015·Granted Nov 28, 2017·3 cites·24 claims
- 3490US10138507B2Manufacturing methods for production of RNA transcriptsMODERNATX INC·Filed 2014·Granted Nov 27, 2018·6 cites·9 claims
- 3589US10849920B2Methods for therapeutic administration of messenger ribonucleic acid drugsMODERNATX INC·Filed 2016·Granted Dec 1, 2020·3 cites·16 claims
- 3689US2025170228A1Terminally modified rnaMODERNATX INC·Filed 2024·Application pending·0 cites
- 3788US11268077B2Materials and methods for treatment of hemoglobinopathiesVERTEX PHARMA·Filed 2019·Granted Mar 8, 2022·6 cites·26 claims
- 3885US11590157B2Methods for therapeutic administration of messenger ribonucleic acid drugsMODERNATX INC·Filed 2020·Granted Feb 28, 2023·1 cites·25 claims
- 3983US12246030B2Methods for therapeutic administration of messenger ribonucleic acid drugsMODERNATX INC·Filed 2023·Granted Mar 11, 2025·0 cites·32 claims
- 4081US2021115101A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2019·Application pending·0 cites
- 4179US2021299278A1Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2020·Application pending·0 cites
- 4278US2024226339A1Materials and Methods for Treatment of HemoglobinopathiesVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 4376US12023371B2Terminally modified RNAMODERNATX INC·Filed 2020·Granted Jul 2, 2024·0 cites·16 claims
- 4476US11708396B2Signal-sensor polynucleotides for the alteration of cellular phenotypesMODERNATX INC·Filed 2021·Granted Jul 25, 2023·0 cites·33 claims
- 4572US2018086807A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2017·Application pending·0 cites
- 4672US2025242061A1Materials and Methods for Treatment of HemoglobinopathiesVERTEX PHARMA·Filed 2025·Application pending·0 cites
- 4772US2025041349A1CRISPR-CAS9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells and Uses ThereofVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 4871US2019240351A1Modified polynucleotides for the production of proteinsMODERNATX INC·Filed 2017·Application pending·0 cites
- 4971US2025140342A1Genotyping cells using single-cell dna sequencing dataVOR BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 5070US2023146324A1Multiparametric nucleic acid optimizationMODERNATX INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 96 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tirtha Chakraborty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →